Wednesday 14 October 2026
Export ALHC’s income statement to Excel — free account
Alignment Healthcare, Inc.
ALHC Healthcare Healthcare Plans
Alignment Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 46.1% from fiscal 2024. In the quarter to June 2026, revenue grew 31.6%, EPS grew 125.0%, free cash flow fell 229.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
8.30
0.21
+2.60%
Follow ALHC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 7 | 6 | 6 |
+8 more TTM periods Free account |
| 20.04% | 12.54% | (0.52%) | (15.00%) | ||
| 3.57% | 1.84% | (0.08%) | (2.32%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
7.49% | 4.09% | (0.16%) | (4.72%) | |
Average Days of Receivables |
23.67 | 23.81 | 23.41 | 22.06 | |
Free Cash Flow per Share |
0.86 | 1.10 | 0.57 | 0.76 | |
Free Cash Flow |
177.51 | 226.18 | 113.22 | 150.63 | |
Capital Expenditures |
(28.03) | (25.82) | (26.71) | (30.96) | |
| Other line items | |||||
Cash ROIC |
13.75% | 18.00% | 10.23% | 13.35% | |
Accounts Receivable Turnover |
15.79 | 17.31 | 19.40 | 20.28 | |
Accounts Payable Turnover |
7.08 | 6.69 | 8.44 | 7.20 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
58.82 | 67.57 | 53.57 | 64.49 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.05 | 0.00 | 0.02 | 0.18 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
10.66% | 10.82% | 11.23% | 11.54% | |
Share Based Compensation of Revenue |
1.34% | 1.38% | 1.57% | 1.79% | |
Interest Coverage |
3.39 | 2.24 | 0.93 | 0.14 | |
Operating CF/Net income |
5.05 | 12.72 | (193.27) | (8.73) | |
Depreciation/Fixed assets |
0.49 | 0.49 | 0.48 | 0.44 | |
Capex/Depreciation |
(0.86) | (0.82) | (0.86) | (1.05) | |
Revenue per Share |
22.06 | 20.73 | 19.94 | 18.27 | |
Operating CF per Share |
0.99 | 1.23 | 0.71 | 0.91 | |
Capex per Share |
(0.14) | (0.13) | (0.13) | (0.16) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates